Evidence map›Paper›PMID 41184761›Full record

ArticleBMC cancer2025

Machine learning-based prediction of invasiveness in lung adenocarcinoma presenting as ground-glass nodules using radiomics and clinical CT features.

Mingzhi Lin, Longqian Li, Yiming Hui, Bin Li, Yue Li, ChongRui Li, Zhizhong Zheng, Zhuowen Yang

Abstract readMulticenter Study
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mingzhi Lin *Department of Thoracic Surgery, The Second Hospital & Clinical Medical School, Lanzhou University, 82 Cuiyingmen, Chengguan District, Lanzhou, 730030, China.
Longqian Li *Department of Thoracic Surgery, The Second Hospital & Clinical Medical School, Lanzhou University, 82 Cuiyingmen, Chengguan District, Lanzhou, 730030, China.
Yiming Hui *Department of Thoracic Surgery, The Second Hospital & Clinical Medical School, Lanzhou University, 82 Cuiyingmen, Chengguan District, Lanzhou, 730030, China.
Bin LiDepartment of Thoracic Surgery, The Second Hospital & Clinical Medical School, Lanzhou University, 82 Cuiyingmen, Chengguan District, Lanzhou, 730030, China. leebin@lzu.edu.cn.
Yue LiThe Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China.
ChongRui LiDepartment of Thoracic Surgery, The Second Hospital & Clinical Medical School, Lanzhou University, 82 Cuiyingmen, Chengguan District, Lanzhou, 730030, China.
Zhizhong ZhengDepartment of Thoracic Surgery, The Second Hospital & Clinical Medical School, Lanzhou University, 82 Cuiyingmen, Chengguan District, Lanzhou, 730030, China.
Zhuowen YangDepartment of Thoracic Surgery, The Second Hospital & Clinical Medical School, Lanzhou University, 82 Cuiyingmen, Chengguan District, Lanzhou, 730030, China.

Funding

lanzhou university No. (20)0458Shandong Provincial Natural Science Foundation ZR2024MH305The development of scientific and technological innovation in Yantai City 2024YT06000818
6 · The paper itself

Abstract

backgroundLung adenocarcinoma(LA), the predominant histological subtype of lung cancer, frequently manifests as ground-glass nodules (GGNs) on computed tomography. Preoperative discrimination of invasiveness—critical for guiding surgical and therapeutic decisions—remains challenging due to subjective radiological assessment and limited sensitivity of conventional methods. This multicenter study aimed to develop a robust, non-invasive predictive framework integrating radiomics and clinical CT features using machine learning (ML) to stratify GGN-associated LA invasiveness.

methodsA retrospective dual-cohort analysis was conducted on 357 patients with pathologically confirmed LA. The primary cohort (n = 312) was randomly divided into a training cohort (n = 249) and a test cohort (n = 63) at an 8:2 ratio. The external validation cohort consisted of 45 patients. Radiomics features (n = 1129) were extracted from High Resolution CT (HRCT), and clinical CT features (n = 16) were evaluated by blinded radiologists. Principal component analysis (PCA) and least absolute shrinkage and selection operator (LASSO) were respectively used for dimensionality reduction of radiomics features and five ML algorithms (XGBoost, SVM, Random Forest, Logistic Regression, LightGBM) were trained to predict invasiveness (low: minimally invasive adenocarcinoma/Grade 1 invasive adenocarcinoma; high: Grade 2/3 invasive adenocarcinoma). Model performance was assessed using Area Under the Curve (AUC), sensitivity, specificity, and Decision Curve Analysis. The calibration curve was plotted, and SHapley Additive exPlanations methods were used to interpret the predictive models.

resultsThe Random Forest model In the Clinical CT Features-PCA radiomics model performed the best, with an AUC value of 0.854 for the training cohort, 0.769 for the test cohort, and 0.778 for the external validation cohort. Key predictive features included PCA-derived radiomic components and clinical CT Features. Clinical CT Features-PCA Radiomics RF model significantly outperformed clinical-only models and Clinical CT Features-LASSO Radiomics Model, showing superior predictive ability.

conclusionsIntegration of radiomics and clinical CT features via ML, particularly RF, enables accurate preoperative prediction of LA invasiveness in GGNs. This approach enhances objectivity over conventional radiological assessment and may optimize personalized treatment strategies. Further validation in larger, prospective cohorts is warranted to confirm clinical utility.

Indexed as

Adenocarcinoma of LungLung NeoplasmsMachine LearningTomography, X-Ray ComputedAgedBoosting Machine Learning AlgorithmsClassification AlgorithmsFemaleHumansMaleMiddle AgedNeoplasm InvasivenessPredictive Learning ModelsRadiomicsRandom ForestRetrospective StudiesGround-Glass noduleLung adenocarcinomaMachine learningPrincipal component analysisRadiomics

Identifiers

PMID41184761
PMCPMC12581264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.